Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies (Q80209074)
Jump to navigation
Jump to search
scientific article published on 01 September 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies |
scientific article published on 01 September 2006 |
Statements
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies (English)
Karen W L Yee
Zhihong Zeng
Marina Konopleva
Farhad Ravandi
Alessandra Ferrajoli
Deborah Thomas
William Wierda
Efrosyni Apostolidou
Susan O'Brien
Michael Andreeff
Francis J Giles
1 September 2006